|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unit of Drug Target Discovery, Division of Cellular and Molecular Pharmacology, Department of Experimental Medical Science, Lund University, Lund, Sweden (J.E., C.S., L.M.F.L-L.); and Ernest Gallo Clinic and Research Center, University of California, San Francisco, California (J.L.W.)
Upon sustained insult, kinins are released and many kinin responses, such as inflammatory pain, adapt from a B2 receptor (B2R) type in the acute phase to a B1 receptor (B1R) type in the chronic phase. In this study, we show that kinins modulate receptor endocytosis to rapidly decrease B2R and increase B1R on the cell surface. B2Rs, which require agonist for activity, are stable plasma membrane components without agonist but recruit
-arrestin 2, internalize in a clathrin-dependent manner, and recycle rapidly upon agonist treatment. In contrast, B1Rs, which are inducible and constitutively active, constitutively internalize without agonist via a clathrin-dependent pathway, do not recruit
-arrestin 2, bind G protein-coupled receptor sorting protein, and target lysosomes for degradation. Agonist delays B1R endocytosis, thus transiently stabilizing the receptor. Most of the receptor trafficking phenotypes are transplantable from one receptor to the other through exchange of the C-terminal receptor tails, indicating that the tails contain epitopes that are important for the binding of protein partners that participate in the endocytic and postendocytic receptor choices. It is noteworthy that the agonist delay of B1R endocytosis is not transplanted to the B2R via the B1R tail, suggesting that this property of the B1R requires another domain. These events provide a rapid kinin-dependent mechanism for 1) regulating the constitutive B1R activity and 2) shifting the balance of accessible receptors in favor of B1R.
Address correspondence to: L.M. Fredrik Leeb-Lundberg, Department of Experimental Medical Science, Lund University, BMC, A12, S-22184 Lund, Sweden. E-mail: fredrik.leeb-lundberg{at}med.lu.se
This article has been cited by other articles:
![]() |
R. Kahn, T. Hellmark, L. M. F. Leeb-Lundberg, N. Akbari, M. Todiras, T. Olofsson, J. Wieslander, A. Christensson, K. Westman, M. Bader, et al. Neutrophil-Derived Proteinase 3 Induces Kallikrein-Independent Release of a Novel Vasoactive Kinin J. Immunol., June 15, 2009; 182(12): 7906 - 7915. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sanden, J. Enquist, S. H. Bengtson, H. Herwald, and L. M. F. Leeb-Lundberg Kinin B2 Receptor-Mediated Bradykinin Internalization and Metalloendopeptidase EP24.15-Dependent Intracellular Bradykinin Degradation J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xia, X.-P. Dun, P.-S. Hu, S. Kjaer, K. Zheng, Y. Qian, C. Solen, T. Xu, B. Fredholm, T. Hokfelt, et al. Postendocytotic traffic of the galanin R1 receptor: A lysosomal signal motif on the cytoplasmic terminus PNAS, April 8, 2008; 105(14): 5609 - 5613. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. M. Quintao, G. F. Passos, R. Medeiros, A. F. Paszcuk, F. L. Motta, J. B. Pesquero, M. M. Campos, and J. B. Calixto Neuropathic Pain-Like Behavior after Brachial Plexus Avulsion in Mice: The Relevance of Kinin B1 and B2 Receptors J. Neurosci., March 12, 2008; 28(11): 2856 - 2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Thompson, M. Pusch, and J. L. Whistler Changes in G Protein-coupled Receptor Sorting Protein Affinity Regulate Postendocytic Targeting of G Protein-coupled Receptors J. Biol. Chem., October 5, 2007; 282(40): 29178 - 29185. [Abstract] [Full Text] [PDF] |
||||